WebNSE: HIKAL BSE: 524735 SECTOR: Pharmaceuticals & Drugs 54k 330 47 281.65 -0.50 (-0.18%) NSE: 31 Mar 03:59 PM Price Summary Today's High ₹ 291.90 Today's Low ₹ 277.35 52 Week High ₹ 456 52 Week Low ₹ 212 FinStar Ownership Stable Ownership strength is slightly missing the benchmark. Valuation Expensive WebCompany built on enduring relationships. Established in 1988, Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals … Hikal offers solutions across the life sciences value chain. We provide world … Hikal serves pharmaceutical companies from early lead generation till … Hikal partners with crop protection companies for custom synthesis and … The Mahad plant was the first manufacturing site of Hikal. Established … Overview. Our Research & Technology division partners with innovator … Hikal Investor Presentation Feb 2015. PDF Hikal Investor Presentation November … Motto. Just the right chemistry. Mission. To create value through superior, chemical … Our partnership approach has resulted in long-term relationships with global …
Hikal Ltd. Brokerage/Research Reports, analyst Research Reports
Web6 gen 2024 · Hikal Limited Indoco Remedies Limited IOL Chemicals and Pharmaceuticals Ltd. Ipca Laboratories Limited JB Chemicals and Pharmaceuticals Ltd. Jubilant Pharmova Limited Laurus Labs Limited Lupin Limited Marksans Pharma Limited Morepen Laboratories Limited Natco Pharma Limited Neuland Laboratories Limited Novartis India Limited … WebPharmaceuticals: Major Website hikal.com CEO Sameer Jai Hiremath Headquarters Mumbai Employees 2.85K Founded 1988 Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. It operates through the Crop Protection and Pharmaceuticals segments. kali fern wifi cracker使用
PRODUCT LIST - APIs - Hikal
WebDr K Nagarajan is no more today. he had cardiac arrest at 92 age in Bangalore India 🇮🇳 He was my mentor at Searle 43 comentarios en LinkedIn Web5 mag 2024 · Hikal shares hit 10% upper circuit after co signs contract with leading global pharma firm By CNBCTV18.com May 5, 2024 1:21 PM IST (Updated) Mini Shares of Hikal were locked in the 10 percent upper circuit of Rs 313,65 per share after the company signed a multi-year contract with a leading global pharmaceutical company. WebApr 2004 - Dec 20139 years 9 months. Mumbai. Was Head of Pharmaceutical business at Hikal during the captioned period. Hikal specialised in manufacturing of APIs, Generics and custom manufacturing for big pharma companies of international repute. Operations mainly in the regulated markets and almost 100% exports to North America, Europe and ... kali fashion women\u0027s floral fitted blazer